Its role FEED
NNE A/S, operating under the brand NNE, is a Danish engineering company specializing in the design, construction, qualification, and optimization of pharmaceutical manufacturing facilities. Its core expertise lies in active pharmaceutical ingredient (API) production, process engineering, automation and IT integration, facility design, logistics, and compliance with stringent GMP regulations for the pharma and biotech sectors.
The company traces its roots to the 1930s within the Novo and Nordisk organizations and was formally demerged as an independent entity, Novo Nordisk Engineering A/S, in 1991. It later operated as NNE Pharmaplan before simplifying its name to NNE in 2017. Headquartered in Virum near Copenhagen, Denmark, with additional offices in the United States and India, NNE employs between 2,000 and 3,500 professionals and manages approximately 1,300 projects annually. It serves pharmaceutical clients globally with end-to-end engineering solutions from conceptual design through to operational support.
NNE is a wholly owned subsidiary of Novo Nordisk A/S and maintains a strategic focus on Denmark, the US, and India following divestments in other markets. It holds a leading position in specialized pharma engineering in Denmark and is recognized for delivering complex, large-scale projects, including its role as engineering partner on major expansions for its parent company.
Also known as Novo Nordisk Engineering A/S, NNE Pharmaplan A/S, and Novo Nordisk Engineering.
chemXplore tracks 1 project involving NNE, of which one is active.
1 more active project is in the record. See all 1 in chemXplore
The €5.6 billion investment will expand API and packaging capacity, create 800 jobs, and enhance sustainability. Completion is expected between 2025-2029, with 3,000 external workers during construction.
active all projects